The autophagy findings were closely reflected in our data examining tumor cell killing, where the dose-dependent killing effect was profoundly reduced with knock down of Beclin1 or ATG5 but remained present in cells that had ATM or AMPKα knocked down. Here, BECN1 is linked to neoplasm.